City

Ch'ang-ch'un (1)

Changsha (1)

Dresden (1)

Nanchang (1)

Nanning (1)

Tianjin (1)

Wuhan (1)

Xi'an (1)

Zhengzhou (1)

Condition

T-LGL Leukemia (2)

CLL (1)

Clpd-Nk (1)

HCL (1)

Leukemia, Prolymphocytic, B-Cell (1)

Leukemia, Prolymphocytic, T-Cell (1)

NK-LGL Leukemia (1)

Richter´s Transformation (1)

SLL (1)

Overall Status

Recruiting (2)

Phase

phase 2/phase 3 (1)

Sponsor

German CLL Study Group (1)

Institute of Hematology & Blood Diseases Hospital (1)

Collaborator

Central South University (1)

First Affiliated Hospital of Guangxi Medical University (1)

Henan Cancer Hospital (1)

The First Affiliated Hospital of Nanchang University (1)

The First Hospital of Jilin University (1)

Tianjin First Central Hospital (1)

Intervention

thalidomide + prednisone + methotrexate (1)

Study Documents

Intervention Type

drug (1)

Funder Type

Other (2)

Study Type

Interventional (1)

Observational [Patient Registry] (1)

T-LGL Leukemia

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

CLL, SLL, HCL Trial in Dresden

Recruiting

CLL
+7 more

Dresden, Sachsen, Germany

BAG Freiberg-Richter, Jacobasch, Wolf, Illmer

Apr 29, 2022

T-LGL Leukemia, Clpd-Nk Trial in China (thalidomide + prednisone + methotrexate)

Recruiting

T-LGL Leukemia
Clpd-Nk

thalidomide + prednisone + methotrexate

Nanning, Guangxi, China
+8 more

Jun 26, 2020